Korea
/DISREGARD RELEASE: AIMMO Inc/
We are advised by AIMMO Inc that journalists and other readers should disregard the news release, AIMMO Enters Partnership with Mitsubishi Electric for Data Supply, issued13-Mar-2024 over PR Newswire, as the release contained erroneous information. ...
Lunit SCOPE AI Enhances Pathologist Concordance and Accuracy in HER2, ER, and PR Assessment - New Study in Breast Cancer Research
- Lunit SCOPE HER2 and Lunit SCOPE ER/PR significantly improve pathologist concordance and accuracy, paving the way for improved breast cancer molecular subtype analysis for informed decision-making and precision patient care SEOUL, South Korea, March 14, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ...
SurplusGLOBAL Leads with Sustainable Value Creation Based on Legacy Semiconductor Equipment at SEMICON China 2024
SEOUL, South Korea, March 13, 2024 /PRNewswire/ -- SurplusGLOBAL (Booth No. N2351), a leader in the legacy semiconductor equipment sector, is set to make a significant impact at SEMICONCHINA 2024. The company, specializing in legacy semiconductor equipment and parts, plans to showcase customized ...
Update on Lunit's Acquisition of Volpara: New Zealand High Court Initial Approval Secured
- Volpara shareholder meeting to be held on April 12, 2024: Culminating the acquisition journey for Lunit, finalization set for May SEOUL, South Korea, March 13, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...
AITRICS to Participate in HIMSS USA 2024
- Three consecutive years of participation in HIMSS USA - Showcasing 'VitalCare' which is an AI Solution for Predicting Patient Deterioration. SEOUL, South Korea, March 12, 2024 /PRNewswire/ -- AITRICS (CEO Kwang joon Kim), a company specializing in medical artificial intelligence (AI) technology...
STRADVISION Renews ISO 27001 Certification, Solidifying Leadership in Automotive Technology Security
SEOUL, South Korea, March 11, 2024 /PRNewswire/ -- STRADVISION
TiumBio to Initiate Phase 2 Trial of TU2218 for Cancer
* TiumBio will pursue three indications for the TU2218 combination clinical trial with pembrolizumab * TU2218 demonstrated a favorable safety and a synergetic effect with immuno-oncology drugs in preclinical studies BOSTON and SEONGNAM, South Korea, March 11, 2024 /PRNewswire/ -- TiumBio Co.,...
Wellysis and Artella Solutions Launch Innovative Remote Cardiac Monitoring Service in the US.
SEOUL, South Korea, March 8, 2024 /PRNewswire/ -- Wellysis, a digital
healthcare company spun off from Samsung, has announced the launch of remote
cardiac monitoring service in the US in partnership with Artella Solutions
(ARTELLA).
Game Backend SaaS BACKND to Showcase at 'GDC 2024', Introduces Enhanced Chat Service
- Game Backend SaaS BACKND to Showcase at 'GDC 2024' with Dedicated Booth - BACKND Server Introduces Upgraded Chat Service to the Global Market SEOUL, South Korea, March 7, 2024 /PRNewswire/ -- AFI, the operator of BACKND, a game backend SaaS platform, announced its participation with a dedicate...
EDINT wins iF Award 2024 for Proctormatic, a mobile-based AI proctoring service
DAEJEON, South Korea, March 6, 2024 /PRNewswire/ -- EDINT, an AI EdTech
startup, announced onMarch 5th that its mobile-based AI online exam proctoring
service, Proctormatic, has won the world-renowned International Forum (iF)
Design Award 2024.
Neurophet introduces AI-powered brain imaging analysis technology at AD/PD 2024
- Showcases brain imaging analysis technology with key products Neurophet AQUA and Neurophet SCALE PET - Aims to commercialize ARIA analysis and amyloid-positive prediction technology SEOUL, South Korea, March 4, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company f...
KCI, a subsidiary of Samyang Group, won 'Platinum Medal' in EcoVadis ESG Rating, Ranked in the Top 1% worldwide
* Evaluated firstly as a L'Oreal partner in 2013 and achieved the highest rating in 11 years * Efforts to establish an ESG committee, reinforce labor and human rights management, and improve management of partners SEOUL, South Korea, March 4, 2024 /PRNewswire/ -- Samyang Group announced that ...
LG OLED AND SHEPARD FAIREY TAKE STREET ART INTO THE DIGITAL REALM
American Street Artist and Social Activist, Shepard Fairey Chooses LG OLED as His Digital Canvas at Frieze LA SEOUL, South Korea, Feb. 29, 2024 /PRNewswire/ -- At Frieze Los Angeles 2024, LG OLED is joining forces with Shepard Fairey, the acclaimed contemporary street artist, social activist and...
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Pancreatic Cancer
SEOUL, South Korea, Feb. 29, 2024 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced onFeb 27 that the US FDA had granted an orphan drug designation for pancreatic cancer for SNB-101 (API: SN-38), a new polymer nanoparticle drug under development, based on the pre-clinical dat...
Gauss Labs and SK hynix Publish the Latest Results on AI-based Semiconductor Metrology Technology at SPIE AL 2024
- Two joint academic papers on AI-based metrology technology presented - Gauss Labs's innovative technology improves process control and equipment productivity in semiconductor manufacturing - Gauss Labs is at the forefront, leading industrial AI efforts to transform the manufacturing industr...
Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings
- Lunit to unveil four oral presentations and three poster presentations at ECR 2024, highlighting Lunit INSIGHT's expansive capability, ranging from adaptability in different use cases to the potential to replace a human reader in mammography double-reading settings SEOUL, South Korea, Feb. 28...
STRADVISION Surpasses 1 Million Units in Annual Production, Leading the Charge in Automotive Vision Technology
SEOUL, South Korea, Feb. 26, 2024 /PRNewswire/ -- Building on the success of
its groundbreaking SVNet with 3D Perception Technology,STRADVISION
GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj.
* Immuncell-LC Inj. is an autologous Cytokine Induced Killer (CIK) cell therapy approved for Commercial use inSouth Korea as an adjuvant cell therapy for the treatment of Hepatocellular Carcinoma (HCC) after curative resection and has receivedFDA Orphan Drug Designations (ODDs) for liver, brain...
SAPEON collaborates with DOCOMO Innovations for AI services enhancement
SAPEON collaborates with DOCOMO Innovations to conduct a PoC (Proof of Concept)
for providing AI services
SEOUL, South Korea, Feb. 26, 2024 /PRNewswire/ -- SAPEON (CEO Soojung Ryu,
www.sapeon.com
J INTS BIO, Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, accepted for presentation at the upcoming American Association for Cancer Research 2024 meeting in USA (AACR 2024)
SEOUL, South Korea, Feb. 26, 2024 /PRNewswire/ -- J INTS BIO announced on the 26th of month that the Phase 1/2 clinical study of its Novel Oral 4th Generation EGFR TKI "JIN-A02" for the treatment of NSCLC has been accepted for poster presentation at the upcoming American Association for Cancer Re...
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 309 media titles]
2024-04-15 17:33AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
[Picked up by 295 media titles]
2024-04-12 15:14LEGOLAND® School Challenge 2024 Expands Across Asia and Opens for Registration on April 15th
[Picked up by 276 media titles]
2024-04-11 11:00Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
[Picked up by 275 media titles]
2024-04-15 08:00